Biomimetic metal–organic framework nanoparticles for cooperative combination of antiangiogenesis and photodynamic therapy for enhanced efficacy H Min, J Wang, Y Qi, Y Zhang, X Han, Y Xu, J Xu, Y Li, L Chen, K Cheng, ... Advanced Materials 31 (15), 1808200, 2019 | 350 | 2019 |
Reversal of pancreatic desmoplasia by re-educating stellate cells with a tumour microenvironment-activated nanosystem X Han, Y Li, Y Xu, X Zhao, Y Zhang, X Yang, Y Wang, R Zhao, ... Nature communications 9 (1), 3390, 2018 | 318 | 2018 |
Sulforaphane mediates glutathione depletion via polymeric nanoparticles to restore cisplatin chemosensitivity Y Xu, X Han, Y Li, H Min, X Zhao, Y Zhang, Y Qi, J Shi, S Qi, Y Bao, G Nie ACS nano 13 (11), 13445-13455, 2019 | 131 | 2019 |
Modularly designed peptide nanoprodrug augments antitumor immunity of PD-L1 checkpoint blockade by targeting indoleamine 2, 3-dioxygenase X Han, K Cheng, Y Xu, Y Wang, H Min, Y Zhang, X Zhao, R Zhao, ... Journal of the American Chemical Society 142 (5), 2490-2496, 2020 | 115 | 2020 |
Adjuvant lipidoid-substituted lipid nanoparticles augment the immunogenicity of SARS-CoV-2 mRNA vaccines X Han, MG Alameh, K Butowska, JJ Knox, K Lundgreen, M Ghattas, ... Nature Nanotechnology 18 (9), 1105-1114, 2023 | 95 | 2023 |
An extendable star-like nanoplatform for functional and anatomical imaging-guided photothermal oncotherapy X Han, Y Xu, Y Li, X Zhao, Y Zhang, H Min, Y Qi, GJ Anderson, L You, ... ACS nano 13 (4), 4379-4391, 2019 | 77 | 2019 |
Investigating crosstalk between H3K27 acetylation and H3K4 trimethylation in CRISPR/dCas-based epigenome editing and gene activation W Zhao, Y Xu, Y Wang, D Gao, J King, Y Xu, FS Liang Scientific reports 11 (1), 15912, 2021 | 65 | 2021 |
Emerging nanomedicines for anti-stromal therapy against desmoplastic tumors X Han, Y Xu, M Geranpayehvaghei, GJ Anderson, Y Li, G Nie Biomaterials 232, 119745, 2020 | 65 | 2020 |
Inducible and reversible RNA N6-methyladenosine editing H Shi, Y Xu, N Tian, M Yang, FS Liang Nature communications 13 (1), 1958, 2022 | 60 | 2022 |
Synthesis and imaging of biocompatible graphdiyne quantum dots H Min, Y Qi, Y Chen, Y Zhang, X Han, Y Xu, Y Liu, J Hu, H Liu, Y Li, G Nie ACS applied materials & interfaces 11 (36), 32798-32807, 2019 | 54 | 2019 |
In situ combinatorial synthesis of degradable branched lipidoids for systemic delivery of mRNA therapeutics and gene editors X Han, J Xu, Y Xu, MG Alameh, L Xue, N Gong, R El-Mayta, R Palanki, ... Nature Communications 15 (1), 1762, 2024 | 17 | 2024 |
Fast and facile synthesis of amidine-incorporated degradable lipids for versatile mRNA delivery in vivo X Han, MG Alameh, N Gong, L Xue, M Ghattas, G Bojja, J Xu, G Zhao, ... Nature chemistry 16 (10), 1687-1697, 2024 | 11 | 2024 |
A split CRISPR/Cas13b system for conditional RNA regulation and editing Y Xu, N Tian, H Shi, C Zhou, Y Wang, FS Liang Journal of the American Chemical Society 145 (9), 5561-5569, 2023 | 11 | 2023 |
Site‐Specific m6A Erasing via Conditionally Stabilized CRISPR‐Cas13b Editor Y Xu, Y Wang, FS Liang Angewandte Chemie 135 (43), e202309291, 2023 | 4 | 2023 |
On demand CRISPR-mediated RNA N6-methyladenosine editing Y Xu, FS Liang Genes & Diseases 9 (6), 1389, 2022 | 2 | 2022 |
Optimization of the activity and biodegradability of ionizable lipids for mRNA delivery via directed chemical evolution X Han, MG Alameh, Y Xu, R Palanki, R El-Mayta, G Dwivedi, KL Swingle, ... Nature Biomedical Engineering 8 (11), 1412-1424, 2024 | | 2024 |
A CRISPR-based Strategy for Temporally Controlled Site-Specific Editing of RNA Modifications Y Xu, Y Wang, FS Liang Bio-protocol 13 (3), 2023 | | 2023 |
The Emerging Gene Regulatory Landscape Through RNA Modifications, Encyclopedia of Cell Biology, Second Edition (CLB2) YX Fu-Sen Liang | | 2023 |
Studies of Developing CRISPR-Based Chemically Inducible Tools for Site-specific Editing of RNA Modification Y Xu Case Western Reserve University, 2023 | | 2023 |